PF
REGN icon

Phoenix Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Phoenix Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$692K Buy
1,109
+141
+15% +$96K ﹤0.01% 302
2026
Q1 		$748K Buy
968
+157
+19% +$120K 0.01% 255
2025
Q4 		$626K Buy
811
+122
+18% +$82.9K 0.01% 273
2025
Q3 		$387K Buy
689
+106
+18% +$59.9K ﹤0.01% 328
2025
Q2 		$306K Buy
583
+64
+12% +$35.7K ﹤0.01% 340
2025
Q1 		$329K Sell
519
-1,584
-75% -$1.09M 0.01% 288
2024
Q4 		$1.5M Buy
2,103
+336
+19% +$282K 0.02% 196
2024
Q3 		$1.86M Buy
1,767
+817
+86% +$909K 0.03% 190
2024
Q2 		$998K Sell
950
-383
-29% -$371K 0.02% 216
2024
Q1 		$1.28M Buy
1,333
+456
+52% +$434K 0.02% 214
2023
Q4 		$797K Buy
877
+239
+37% +$197K 0.01% 222
2023
Q3 		$535K Sell
638
-739
-54% -$581K 0.01% 254
2023
Q2 		$974K Buy
1,377
+714
+108% +$550K 0.02% 217
2023
Q1 		$533K Buy
+663
New +$500K 0.01% 217
2022
Q4 		– Sell
-447
Closed -$313K – 332
2022
Q3 		$313K Sell
447
-100
-18% -$62.9K 0.01% 278
2022
Q2 		$325K Sell
547
-1,429
-72% -$929K 0.01% 311
2022
Q1 		$1.38M Sell
1,976
-337
-15% -$213K 0.02% 231
2021
Q4 		$1.49M Sell
2,313
-232
-9% -$143K 0.02% 221
2021
Q3 		$1.54M Buy
+2,545
New +$1.58M 0.03% 238
2021
Q2 		– Sell
-2,494
Closed -$1.18M – 388
2021
Q1 		$1.18M Buy
2,494
+1,927
+340% +$938K 0.03% 272
2020
Q4 		$270K Buy
+567
New +$306K 0.01% 317

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Phoenix Financial's REGN Position: Q2 2026 in Review

Phoenix Financial increased its Regeneron Pharmaceuticals (REGN) stake by 15% in Q2 2026, buying an estimated $96K and bringing the position to 1,109 shares worth $692K. The position accounts for ﹤0.01% of the portfolio, ranked #302.

Phoenix Financial first reported a position in REGN in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.86M in Q3 2024. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Phoenix Financial held 1,109 shares of Regeneron Pharmaceuticals worth $692K as of Q2 2026.
  • Phoenix Financial bought 141 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $96K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Phoenix Financial's portfolio in Q2 2026, its #302 holding.
  • Phoenix Financial first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 21 quarters since.
  • Phoenix Financial's Regeneron Pharmaceuticals position peaked at $1.86M in Q3 2024.
  • 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Phoenix Financial's 13F filing for Q2 2026, filed 11 Aug 2026.